Commentary on where is myelodysplastic neoplasm? The missing MDS in indigenous cancer epidemiology
Cancer Epidemiology · 2026-12 · 105 · 103245
DOI: 10.1016/j.canep.2026.103245 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Epidemiology, 2026-12. Verfasst von Shafkat Jahan und 1 weiteren Autor:innen. Beteiligte Einrichtung: The School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, 11 Wyndham Street, Herston, Brisbane…. Die Arbeit nennt 7 Literaturangaben. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, 11 Wyndham Street, Herston, Brisbane, QLD, 4006, Australia. Electronic address: shafkat.jahan@uq.edu.au.
- The School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, 11 Wyndham Street, Herston, Brisbane, QLD, 4006, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Jahan, S., & Garvey, G. (2026). Commentary on where is myelodysplastic neoplasm? The missing MDS in indigenous cancer epidemiology. Cancer Epidemiology, 105, 103245. https://doi.org/10.1016/j.canep.2026.103245
Vancouver
Jahan S, Garvey G. Commentary on where is myelodysplastic neoplasm? The missing MDS in indigenous cancer epidemiology. Cancer Epidemiology. 2026;105:103245. doi:10.1016/j.canep.2026.103245
BibTeX
@article{Jahan2026,
author = {Jahan, Shafkat and Garvey, Gail},
title = {Commentary on where is myelodysplastic neoplasm? The missing MDS in indigenous cancer epidemiology},
journal = {Cancer Epidemiology},
year = {2026},
volume = {105},
pages = {103245},
doi = {10.1016/j.canep.2026.103245}
}
EUVIMED